MedTrace Logo

Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment

NCT00306124 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2007-10-25

No results posted yet for this study

Summary

This study aims to determine whether levodopa is effective in boosting learning and memory in healthy subjects and patients with dementia or Mild Cognitive Impairment.

We also examine in healthy subjects using functional magnetic resonance imaging which brain regions mediate improved learning after levodopa administration.

Conditions

Interventions

DRUG

Levodopa

Sponsors & Collaborators

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Stefan Knecht, MD · Neurology, University of Muenster, Germany

  • Caterina Breitenstein, PhD · Neurology, University of Muenster, Germany

  • Julia Reinholz, PhD · Neurology, University of Muenster, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-01-31
Completion
2008-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00306124 on ClinicalTrials.gov